The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Determinants of infarct size in reperfusion therapy for acute myocardial infarction.
Abstract
BACKGROUND: Experimental animal studies have demonstrated that myocardium at risk, residual collateral flow, and duration of coronary artery occlusion are important determinants of final infarct size. The present study examined these variables in patients with acute myocardial infarction in relation to final infarct size. METHODS AND RESULTS: Myocardium at risk was assessed with hexakis(2-methoxyisobutyl isonitrile) technetium (I) (99mTc sestamibi) in 89 patients with first-time myocardial infarction (anterior, 48 patients; inferior, 41 patients). All patients had successful reperfusion therapy with either intravenous thrombolysis (32 patients) or primary coronary angioplasty (57 patients) within 24 hours of the onset of chest pain (4.7 +/- 3.9 hours; range, 0.5-21.5 hours) documented by coronary angiography. 99mTc sestamibi was injected intravenously before reperfusion therapy, and tomographic imaging was performed 1-6 hours later. Myocardium at risk was quantitated for each patient and expressed as a percentage of the left ventricle: 35 +/- 19%; range, 2-73%. Collateral flow was estimated by both invasive and noninvasive methods. Fifty-three patients with TIMI grade 0 or I flow who underwent primary coronary angioplasty had collateral flow graded angiographically (0-3) before the first balloon inflation. All patients had collateral flow estimated noninvasively from the acute sestamibi short-axis profile curve by three methods that assess the severity of the perfusion defect. Each of these three methods was significantly associated with angiographic collateral grade. Final infarct size was determined at hospital discharge by a second sestamibi study (17 +/- 17%; range, 0-59%). Myocardium at risk (r = 0.61, p less than 0.0001), angiographic collateral grade (p = 0.0003), and radionuclide estimates of collateral flow (r = 0.69-0.70, all p less than 0.0001) were all significantly associated with final infarct size. The time to reperfusion therapy was not significantly associated with final infarct size by univariate analysis (r = 0.18, p = 0.10). Two multivariate models were constructed to determine which variables were independently associated with final infarct size. In the invasive model, myocardium at risk, angiographic collateral grade with an interaction term for infarct location, and time to reperfusion were all independently significant and accounted for 70% of the variability in final infarct size. The noninvasive model, which substituted a radionuclide estimate of collateral flow for angiographic collateral grade, showed nearly identical results, accounting for 68% of the variability in infarct size in patients where the infarct artery was known to be occluded. When all patients were included (patients with and without acute angiography), the noninvasive model accounted for 59% of the variability in infarct size. CONCLUSIONS: Myocardium at risk, collateral flow, and duration of coronary occlusion are each independently associated with final infarct size and account for most of its variability. Ideally, all three parameters should be examined in evaluation of the efficacy of new treatment strategies for acute myocardial infarction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reimer, K. A., & Jennings, R. B. (1979) · PubMed · Cited by 1,219
Cohen, M., & Rentrop, K. P. (1986) · Circulation · doi:10.1161/01.cir.74.3.469 · Cited by 424
Kloner, R. A., Sg, E., Lange, R., & D, E. B. M. (1983) · PubMed · Cited by 362
Reimer, K. A., Jennings, R. B., Cobb, F. R., Murdock, R. H., Greenfield, J. C., Becker, L. C., Bulkley, B. H., Hutchins, G. M., Schwartz, R. P., & Bailey, K. R. (1985) · Circulation Research · doi:10.1161/01.res.56.5.651 · Cited by 358
Self-citationThe Western Washington Intravenous Streptokinase in Acute Myocardial Infarction Randomized Trial.
Kennedy, J. W., Martin, G. V., Davis, K. B., Maynard, C., Stadius, M., Sheehan, F. H., & Ritchie, J. L. (1988) · Circulation · doi:10.1161/01.cir.77.2.345 · Cited by 244
Sheehan, F. H., Mathey, D. G., Schofer, J., Dodge, H. T., & Bolson, E. L. (1985) · Circulation · doi:10.1161/01.cir.71.6.1121 · Cited by 171
Rentrop, K. P., Feit, F., Sherman, W., & Thornton, J. C. (1989) · Circulation · doi:10.1161/01.cir.80.5.1166 · Cited by 159
Myocardial infarct size and location in relation to the coronary vascular bed at risk in man.
Lee, J. T., Ideker, R. E., & Reimer, K. A. (1981) · Circulation · doi:10.1161/01.cir.64.3.526 · Cited by 155
DISCREPANCIES BETWEEN THE EFFECTS OF CORONARY REPERFUSION ON SURVIVAL AND LEFT VENTRICULAR FUNCTION
de Werf, F. V. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92812-2 · Cited by 152
Coster, P. M. D., Wijns, W. C., Cauwe, F., Robert, A. R., Beckers, C., & Melin, J. A. (1990) · Circulation · doi:10.1161/01.cir.82.6.2152 · Cited by 89
Cited by
ACC/AHA guidelines for the management of patients with acute myocardial infarction
Committee Members, Ryan, T. J., Anderson, J. L., Antman, E. M., Braniff, B. A., Brooks, N. H., Califf, R. M., Hillis, L. D., Hiratzka, L. F., Rapaport, E., et al. (1996) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00392-0 · Cited by 1,850
Self-citationAmado, L. C., Saliaris, A. P., Schuleri, K. H., St. John, M., Xie, J.-S., Cattaneo, S., Durand, D. J., Fitton, T., Kuang, J. Q., Stewart, G., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504388102 · Cited by 1,073
Ross, A. M., Gibbons, R. J., Stone, G. W., Kloner, R. A., & Alexander, R. W. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.02.061 · Cited by 610
Self-citationAdenosine as an adjunct to thrombolytic therapy for acute myocardial infarction
Mahaffey, K. W., Puma, J. A., Barbagelata, N. A., DiCarli, M. F., Leesar, M. A., Browne, K. F., Eisenberg, P. R., Bolli, R., Casas, A. C., Molina-Viamonte, V., et al. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00418-0 · Cited by 553
Self-citation
Metadata
- Authors
- Christian, T. F., Schwartz, R. S., & Gibbons, R. J.
- Venue
- Circulation
- Published
- 1992-07
- Volume
- 86
- Issue
- 1
- Pages
- 81-90
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2035981171
- Cited by
- 268
- References
- 10
- FWCI
- 12.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Determinants of infarct size in reperfusion therapy for acute myocardial infarction. https://app.cochat.ai/papers/10.1161/01.cir.86.1.81
- The paper
- Christian, T. F., Schwartz, R. S., & Gibbons, R. J. (1992). Determinants of infarct size in reperfusion therapy for acute myocardial infarction. Circulation. https://doi.org/10.1161/01.cir.86.1.81
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.